Verona pharma to present at h.c. wainwright 23rd annual global investment conference

London and raleigh, n.c., aug. 31, 2021 (globe newswire) -- verona pharma plc (nasdaq: vrna) (“verona pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that david zaccardelli, pharm. d., president and chief executive officer, will present a company overview at the h.c. wainwright 23rd annual global investment conference. the presentation will be available on-demand starting at 7:00 am edt / 12:00 pm bst on monday, september 13, 2021.
VRNA Ratings Summary
VRNA Quant Ranking